PTEN and central nervous system cancer: Manipulation of key genetic drivers have led to glioma formation in mouse models, such as combined mutations of NF1/PTEN/TP53, KRASG12D/AKT or EGFRvIII/Ink4a/PTEN [5, 68–81].